Pharma Manufacturing

Menu

Newsletters
Subscribe

Newsletters
Subscribe

Follow us on:

Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sector

Home|
Solution Providers|
E-News|
Subscribe|
Resource Directory|
Webinars|
Current Issue

Follow us on:

On Pharma

Centocor Watch newsletter

Category: Miscellany

Submitted by pharmamanufacturing on Mon, 03/19/2007 - 21:33

Text of a newsletter sent to J&J shareholders today

Permalink

Show Comments

Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments

Most Popular

Past 7 Days
Past 30 Days
Past 6 Months

01

Mallinckrodt offloads BioVectra for $250 million

The company has agreed to sell its contract manufacturing unit to…
02

Amgen experimental lung cancer drug shows promise in study

More than half of patients with an advanced form of lung cancer initially…
03

Novartis investigational lung cancer therapy grabs breakthrough status

The U.S. FDA has granted Breakthrough Therapy designation to Novartis'…
04

Bayer reduces management board amid ongoing company shake-up

Bayer’s quest to reduce its workforce has traveled all the way up into…
05

Experimental Lilly med shrank nearly 70% of tumors in lung cancer trial

The drug LOXO-292 was acquired by the drugmaker in the beginning of the…

01

Pfizer recalls migraine drug for possible microbial contamination

Pfizer has recalled two lots of migraine drug Relpax after finding those…
02

Boehringer pharma head to step down

Allan Hillgrove, the board member responsible for the company's human…
03

FDA widens generic drug recall probe beyond heart meds

The FDA is reportedly expanding its investigation related into impurities…
04

Blockbuster-bound Lilly drug wins another FDA nod

Eli Lilly’s Taltz has been given the go-ahead for a new indication,…
05

FDA warns Chinese company for drug manufacturing data integrity violations

The organization sent Ningbo Huize Commodity a warning letter for…

01

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.
02

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…
03

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…
04

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…
05

Pharma's budding opportunity

Why the industry is forming bonds with CBD

Pharma Manufacturing

About

General Information
Contact Us
Subscription Services
Media Kit
Editorial Calendar
Editorial Submissions Guidelines
Editorial Advisory Board

Content

Resource Libraries
OpEd
Fundamentals
News
Articles
White Papers
Products
All Star Innovators
Funny Pharm

Magazine

Subscribe (print)
Current Issue
Issue Archive

Site Tools

Site Map
Resource Directory

Stay Connected

My Account
Events Calendar
E-Newsletters
Human Interest
Facebook
Twitter
LinkedIn
YouTube
RSS Feed

Contact Us | Advertise | Privacy Policy | Legal Disclaimers, Terms & Conditions

Copyright © 2004 - 2019 Pharma Manufacturing. All rights reserved.

P: 630-467-1300 | 1501 E. Woodfield Road, Suite 400N, Schaumburg, IL 60173

Chemical Processing | Control | Control Design | Food Processing | Pharma Manufacturing | Plant Services | Smart Industry